View the recording for a captivating webinar as we enter the cutting-edge realm of Large Language Models (LLMs) and their pivotal role in transforming the future of global health, hosted by Tim Lambertus, our Chief Product Officer, with Richard Zuroff, Senior VP of Growth, and James Aufricht, Director of Product.

The challenges posed by infectious diseases demand innovative solutions that go beyond manual efforts. In this webinar, we explored generative and extractive AI, and how LLM technology, the remarkable technology that powers applications like ChatGPT, holds the key to unlocking this potential.

Gone are the limitations of traditional natural language processing; LLMs can be used to synthesize and summarize large swaths of data and intelligence to isolate anomalies and generate actionable outputs but the true brilliance of LLMs lies in their generative AI capabilities. Beyond reading, these applications can listen to data streams, collate information, establish contextual connections, and even produce coherent summaries. This ground-breaking advancement opens new possibilities for health care providers, pharmaceutical firms, medical equipment manufacturers, and others, enabling the contextual awareness of the highest impact events, the rapid generation of insights on those events, speeding up informed decision making.

In this webinar we explored how to begin harnessing the power of LLM technology, ensuring it operates within environments where accuracy and trust are critical to the decisions being made. Imagine having a system that can analyze millions of sources worldwide in a matter of seconds, offering a depth of detail that surpasses human capacity.

View the recording to see how we uncover the latest LLM innovations and use cases in infectious disease intelligence, demonstrating how they can revolutionize disease surveillance and forecasting globally. Don’t miss this opportunity to witness the future of disease intelligence, paving the way for a safer, healthier world.